Clinical Trial Update: Teriflunomide Concentration in Serum and Cerebrospinal Fluid From Patients With Multiple Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 trial update examining teriflunomide concentration in serum and cerebrospinal fluid of patients with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Teriflunomide (teriflunomide)

Snippet

Sponsor: Jan Lycke | Conditions: Multiple Sclerosis, Pharmacokinetics | Phase 4 | Status: COMPLETED